← FDA DRUG APPROVALS
FDA ANDA · ANDA210676
DIPHENHYDRAMINE HCL AND IBUPROFEN
Sponsor: AUROBINDO PHARMA LTD
APPLICATION
ANDA210676
TYPE
ANDA
ORIGINAL APPROVAL
2019-02-14
LATEST ACTION
2019-02-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter
Products
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDEOver-the-counter
DIPHENHYDRAMINE HYDROCHLORIDE 25MG, IBUPROFEN EQ 200MG FREE ACID AND POTASSIUM SALT · CAPSULE · ORAL
Approval history
2019-02-14UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.